Product Information

TICAGRELOR 60 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.2624 per EA under NDC 00378221491. Its NADAC has been published 55 times since Oct 29, 2025.

FDA first approved this application on Jul 9, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Ticagrelor market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TICAGRELOR 60 MG TABLET

Ticagrelor
$0.2624per EA
High Outlier

Strength

60 mg/1

NDC

00378221491

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TICAGRELOR

Approval Type

Generic (ANDA)

FDA Application

ANDA208597

FDA Approved

7/9/2021

TE Code

AB

On Market Since

9/25/2025

Pharmacological Classes

Cytochrome P450 3A4 Inhibitors
Decreased Platelet Aggregation
P-Glycoprotein Inhibitors
P2Y12 Platelet Inhibitor
P2Y12 Receptor Antagonists

Price Statistics

The NADAC for TICAGRELOR 60 MG TABLET has been published 55 times since Oct 29, 2025, and over the history we have for it it has declined 95.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2624 per EA
All-time high$5.9399 (Nov 12, 2025)
All-time low$0.2624 (Oct 21, 2026)
52-week high$5.8493
52-week low$0.2624
Median price$0.3240
Average price$1.9630
Largest weekly change-73.8% (Mar 18, 2026)
Weeks tracked55
Tracking sinceOct 29, 2025

Price History

1W

0.0%

1M

-7.0%

3M

-15.2%

6M

-17.9%

1Y

-95.6%

3Y

N/A

5Y

N/A

All

-95.6%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TICAGRELOR 60 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TICAGRELOR 60 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.2624 per EA (NDC 00378221491), effective Nov 11, 2026.

How has the price of TICAGRELOR 60 MG TABLET changed over time?

Over the history we have for it, the NADAC for TICAGRELOR 60 MG TABLET has declined 95.6%. It has been tracked across 55 weekly CMS publications since Oct 29, 2025.

What are the highest and lowest recorded NADAC prices for TICAGRELOR 60 MG TABLET?

Since Oct 29, 2025, the NADAC for TICAGRELOR 60 MG TABLET has ranged from a low of $0.2624 (Oct 21, 2026) to a high of $5.9399 (Nov 12, 2025), with a median of $0.3240 per EA.

Are there cheaper alternatives to TICAGRELOR 60 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TICAGRELOR 60 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TICAGRELOR 60 MG TABLET?

TICAGRELOR 60 MG TABLET (NDC 00378221491) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.